Estuardo Aguilar-Cordova, M.D., inf.
2021
In 2021, Estuardo Aguilar-Cordova, M.D., inf. earned a total compensation of $526.4K as Founder and Former Chief Executive Officer and Chief Scientific Officer at Candel Therapeutics, a 29% decrease compared to previous year.
Compensation breakdown
| Salary | $520,192 |
|---|---|
| Other | $6,194 |
| Total | $526,386 |
inf received $520.2K in salary, accounting for 99% of the total pay in 2021.
inf also received $6.2K in other compensation.
Rankings
In 2021, Estuardo Aguilar-Cordova, M.D., inf.'s compensation ranked 10,616th out of 12,406 executives tracked by ExecPay. In other words, inf earned more than 14.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,616 out of 12,406 | 14th |
Division Manufacturing | 4,687 out of 5,492 | 15th |
Major group Chemicals And Allied Products | 2,107 out of 2,368 | 11th |
Industry group Drugs | 1,871 out of 2,089 | 10th |
Industry Biological Products, Except Diagnostic Substances | 416 out of 452 | 8th |
Source: SEC filing on September 2, 2022.
inf's colleagues
We found three more compensation records of executives who worked with Estuardo Aguilar-Cordova, M.D., inf. at Candel Therapeutics in 2021.